These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36099026)

  • 21. Phase-transition W/O Microemulsions for Ocular Delivery: Evaluation of Antibacterial Activity in the Treatment of Bacterial Keratitis.
    Bharti SK; Kesavan K
    Ocul Immunol Inflamm; 2017 Aug; 25(4):463-474. PubMed ID: 26943481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Mucoadhesive Polymeric Formulation on Corneal Permeation of Fluoroquinolones.
    Gade SK; Shivshetty N; Sharma N; Bhatnagar S; Garg P; Venuganti VVK
    J Ocul Pharmacol Ther; 2018 Oct; 34(8):570-578. PubMed ID: 30136888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
    Kowalski RP; Dhaliwal DK; Karenchak LM; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan/β-glycerophosphate in situ forming thermo-sensitive hydrogel for improved ocular delivery of moxifloxacin hydrochloride.
    Asfour MH; Abd El-Alim SH; Awad GEA; Kassem AA
    Eur J Pharm Sci; 2021 Dec; 167():106041. PubMed ID: 34655737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization.
    Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH
    Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The wound healing and antibacterial potential of triple-component nanocomposite (chitosan-silver-sericin) films loaded with moxifloxacin.
    Shah A; Ali Buabeid M; Arafa EA; Hussain I; Li L; Murtaza G
    Int J Pharm; 2019 Jun; 564():22-38. PubMed ID: 31002933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiologic, Pharmacokinetic, and Clinical Effects of Corneal Collagen Cross-Linking on Experimentally Induced Pseudomonas Keratitis in Rabbits.
    Cosar CB; Kucuk M; Celik E; Gonen T; Akyar I; Serteser M; Tokat F; Ince U
    Cornea; 2015 Oct; 34(10):1276-80. PubMed ID: 26226468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carboxylated nanofibrillated cellulose empowers moxifloxacin to overcome Staphylococcus aureus biofilm in bacterial keratitis.
    Malani M; Thodikayil AT; Saha S; Nirmal J
    Carbohydr Polym; 2024 Jan; 324():121558. PubMed ID: 37985120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
    Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular Permeation of Topical Tazocin and Its Effectiveness in the Treatment of Pseudomonas aeruginosa Induced Keratitis in Rabbits.
    Singh S; Agarwal R; Razak ZA; Ngu R; Nyein LL; Vasudevan S; Kapitonova M; Kadir AJ; Visvaraja S
    J Ocul Pharmacol Ther; 2018; 34(1-2):214-223. PubMed ID: 29341837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moxifloxacin-Gelrite in situ ophthalmic gelling system against photodynamic therapy for treatment of bacterial corneal inflammation.
    El-Laithy HM; Nesseem DI; El-Adly AA; Shoukry M
    Arch Pharm Res; 2011 Oct; 34(10):1663-78. PubMed ID: 22076767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and In Vitro/Ex Vivo Evaluation of Moxifloxacin-Loaded PLGA Nanosuspensions for Ophthalmic Application.
    Mudgil M; Pawar PK
    Sci Pharm; 2013; 81(2):591-606. PubMed ID: 23833723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crosslinked polymer nanocapsules for therapeutic, diagnostic, and theranostic applications.
    Sun H; Erdman W; Yuan Y; Mohamed MA; Xie R; Wang Y; Gong S; Cheng C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Nov; 12(6):e1653. PubMed ID: 32618433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and evaluation of alginate-chitosan nanocapsules for controlled release of acetamiprid.
    Kumar S; Chauhan N; Gopal M; Kumar R; Dilbaghi N
    Int J Biol Macromol; 2015 Nov; 81():631-7. PubMed ID: 26321424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic and Pharmacodynamic Evaluation of Gemifloxacin Chitosan Nanoparticles As an Antibacterial Ocular Dosage Form.
    Hassan HAFM; Ali AI; ElDesawy EM; ElShafeey AH
    J Pharm Sci; 2022 May; 111(5):1497-1508. PubMed ID: 34929155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corneal delivery of moxifloxacin and dexamethasone combination using drug-eluting mucoadhesive contact lens to treat ocular infections.
    Gade SK; Nirmal J; Garg P; Venuganti VVK
    Int J Pharm; 2020 Dec; 591():120023. PubMed ID: 33127488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moxifloxacin Hydrochloride-Loaded Eudragit® RL 100 and Kollidon® SR Based Nanoparticles: Formulation, In vitro Characterization and Cytotoxicity.
    Kırımlıoğlu GY; Özer S; Büyükköroğlu G; Yazan Y
    Comb Chem High Throughput Screen; 2021; 24(3):328-341. PubMed ID: 32342810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro susceptibility of bacterial keratitis isolates to fourth-generation fluoroquinolones.
    Chawla B; Agarwal P; Tandon R; Titiyal JS; Sharma N; Agarwal T; Navak N; Satpathy G
    Eur J Ophthalmol; 2010; 20(2):300-5. PubMed ID: 19924668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chitosan gel containing polymeric nanocapsules: a new formulation for vaginal drug delivery.
    Frank LA; Sandri G; D'Autilia F; Contri RV; Bonferoni MC; Caramella C; Frank AG; Pohlmann AR; Guterres SS
    Int J Nanomedicine; 2014; 9():3151-61. PubMed ID: 25061292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B.
    Zhou W; Wang Y; Jian J; Song S
    Int J Nanomedicine; 2013; 8():3715-28. PubMed ID: 24106427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.